HIRSCHMAN ORIN 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-09 4:05 pm Sale |
2024-10-02 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
HIRSCHMAN ORIN | 0 0.000% |
-1,061,509 (Position Closed) |
Filing |
| 2024-02-07 09:15 am Purchase |
2024-01-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
HIRSCHMAN ORIN | 1,061,509 8.200% |
1,061,509 (New Position) |
Filing |